Sort   by:  
 Page size 
UnknownHER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade.
Not available
S-EPMC7850037 | biostudies-literature
UnknownPhenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade.
Not available
S-EPMC6971277 | biostudies-literature
UnknownImmune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer.
Not available
S-EPMC7979716 | biostudies-literature
UnknownA prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.
Not available
S-EPMC12056793 | biostudies-literature
Sort   by:  
 Page size